期刊
EPILEPSY RESEARCH
卷 92, 期 2-3, 页码 253-257出版社
ELSEVIER
DOI: 10.1016/j.eplepsyres.2010.10.003
关键词
Thalidomide; Antiepileptic drugs; Refractory epilepsy; Sedative drugs
资金
- National Council of Science and Technology of Mexico (CONACyT) [013758]
We have experimentally shown that thalidomide has strong anticonvulsant properties. In an open label study, eight male patients with refractory epilepsy received thalidomide at daily-doses of 200 mg during 1 year, frequency of seizures before and during treatment were compared. The mean number of seizures before thalidomide administration was 26 +/- 4 per month; it decreased to 7 +/- 1 along thalidomide therapy. Our results indicate that thalidomide has strong therapeutic effects in refractory epilepsy. (C) 2010 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据